Zhiyuan You

Zhiyuan You

Auto-generated profile, based on publicly available information

Zhiyuan You

Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhiyuan You
Zhiyuan You
WJWen-Xue Jiang
Wen-Xue Jiang
LQLing-Yun Qin
Ling-Yun Qin
ZGZhou Gong
Zhou Gong
WWWei Wan
Wei Wan
WLWei Liu
Wei Liu
Autophagy receptor p62/SQSTM1 promotes the assembly and removal of ubiquitylated proteins by forming p62 bodies and mediating their encapsulation in autophagosomes. Here we show that under nutrient-deficient conditions, cellular p62 specifically undergoes acetylation, which is required for the formation and subsequent autophagic clearance of p62 bodies. We identify K420 and K435 in the UBA domain as the main acetylation sites, and TIP60 and HDAC6 as the acetyltransferase and deacetylase. Mechanically, acetylation at both K420 and K435 sites enhances p62 binding to ubiquitin by disrupting UBA dimerization, while K435 acetylation also directly increases the UBA-ubiquitin affinity. Furthermore, we show that acetylation of p62 facilitates polyubiquitin chain-induced p62 phase separation. Our results suggest an essential role of p62 acetylation in the selective degradation of ubiquitylated proteins in cells under nutrient stress, by specifically regulating the assembly of p62 bodies.

12 May 2023 in Immunological Reviews
Verified
Journal Article
Closed access
ZYZhiyuan You
Zhiyuan You
HCHongbo Chi
Hongbo Chi

2 April 2026 in Science
Verified
Journal Article
Closed access
ZYZhiyuan You
Zhiyuan You
JKJiyeon Kim
Jiyeon Kim
CGChuansheng Guo
Chuansheng Guo
HHHaoran Hu
Haoran Hu
NCNicole M. Chapman
Nicole M. Chapman
HCHongbo Chi
Hongbo Chi
Antitumor immunity requires conventional type 1 dendritic cells (cDC1s). How cDC1s maintain functional fitness in the tumor microenvironment remains unclear. In this study, we established that intratumoral cDC1s exhibited discrete mitochondrial states and that OPA1-mediated mitochondrial energy and redox metabolism dictated cDC1 antitumor responses. Mechanistically, OPA1 orchestrated antigen presentation and the CD8 + T cell priming function of cDC1s by promoting nuclear respiratory factor 1 (NRF1) expression and electron transport chain integrity, thereby supporting bioenergetics and NAD + /NADH balance. During tumor progression, mitochondrial membrane potential and volume, as well as OPA1-NRF1 signaling, declined in intratumoral cDC1s. Furthermore, intratumoral administration of cDC1s with polarized mitochondria showed immunotherapeutic benefits in mice, particularly in combination with immune checkpoint blockade. Collectively, our findings reveal mitochondrial metabolism and signaling as putative targets to reinvigorate cDC1 function for cancer immunotherapy.

24 October 2025 in Science Immunology
Verified
Journal Article
Closed access
JSJordy Saravia
Jordy Saravia
NCNicole M. Chapman
Nicole M. Chapman
YSYu Sun
Yu Sun
XMXiaoxi Meng
Xiaoxi Meng
IRIsabel Risch
Isabel Risch
HCHongbo Chi
Hongbo Chi
Immunotherapies targeting regulatory T (T reg ) cells often trigger inflammation and autoimmunity. How T reg cells undergo functional reprogramming to reestablish immune homeostasis under these conditions remains unclear. Here, we demonstrate that mitochondrial and lysosomal signaling orchestrates T reg cell metabolic and functional fitness. T reg cell–specific loss of the mitochondrial protein Opa1 led to disrupted immune homeostasis and pronounced inflammation, and reduced the generation of T reg cells with high mitochondrial metabolic and suppressive function. Opa1 deletion triggered mitochondrial bioenergetic stress, associated with increased adenosine monophosphate–activated protein kinase (AMPK) signaling and transcription factor EB (TFEB) activation. Further, T reg cell–specific deletion of the lysosomal signaling protein Flcn partially phenocopied Opa1 deficiency–associated inflammation and aberrant TFEB activation, and these effects were rectified by TFEB codeletion. Flcn-deficient T reg cells were enriched in a terminal “metabolic quiescence reset” state and failed to accumulate in nonlymphoid tissues and suppress antitumor immunity. Our study demonstrates that organelle-directed metabolic and signaling processes and mitochondria–lysosome interplay control T reg cell differentiation and function.

13 November 2026 in Nature Reviews Immunology
Verified
Journal Article
Closed access
ZYZhiyuan You
Zhiyuan You
JKJiyeon Kim
Jiyeon Kim
HCHongbo Chi
Hongbo Chi